drugset / Trial / NCT02465645
To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.
RandomizedParallel-groupOpen-labelTreatment
Summary
After successful screening of patients based on inclusion criteria, we will measure the baseline Hepatic Venous Pressure Gradient. At day 1 patients will undergo complete blood investigation including complete haemogram, kidney function test, liver function test, prothrombin time, AFP (Alfa Feto Protein) level, chest x ray, ultrasonography, fibroscan. Routine complete physical examination will be done.
Timeline
- Start
- 2015-06-01
- Primary completion
- 2017-01-31
- Completion
- 2017-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 40 mg | Oral |
| Comparator | Carvedilol | Other / unclassified | 12.5 mg | Oral |